Saturday 17 October 2026
Export TEM’s income statement to Excel — free account
Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
64.72
6.41
−9.01%
Follow TEM
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | 22.89 | 31.36 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | 79.49 | 104.32 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | 2,300 | 2,400 | 3,800 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | 0.00 | 0.23 | 0.29 | 0.33 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | 321 | 532 | 693 | 1,272 | ||||
| Gross margin, % | — | — | — | — | — | — | 40.60 | 53.81 | 54.96 | 62.74 | |||||
| EBT | — | — | — | — | — | — | (289) | (214) | (701) | (291) | |||||
| EBT margin, % | — | — | — | — | — | — | (90.17) | (40.15) | (101.14) | (22.89) | |||||
| Net income | — | — | — | — | — | — | (290) | (214) | (706) | (245) | |||||
| Depreciation | — | — | — | — | — | — | 36 | 40 | 44 | 107 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | 5.09 | 8.40 | 5.79 | 7.30 | ||||
| Earnings | — | — | — | — | — | — | (4.60) | (3.38) | (6.23) | (1.41) | |||||
| Cash flow | — | — | — | — | — | — | (2.67) | (3.39) | (1.58) | (1.25) | |||||
| Capex | — | — | — | — | — | — | (0.29) | (0.55) | (0.18) | (0.16) | |||||
| Free cash flow | — | — | — | — | — | — | (2.96) | (3.93) | (1.76) | (1.41) | |||||
| Book value | — | — | — | — | — | — | (17.91) | (21.83) | 0.47 | 2.82 | |||||
| Shares, m | — | — | — | — | — | — | 63 | 63 | 120 | 174 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | 4.54 | 4.54 | 5.84 | 8.09 | |||||
| P/B | — | — | — | — | — | — | 0.00 | 0.00 | 71.82 | 20.94 | |||||
| EV/Sales | — | — | — | — | — | — | 5.17 | 5.17 | 5.82 | 8.47 | |||||
| EV/FCF | — | — | — | — | — | — | (10.23) | (10.23) | (19.10) | (43.92) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | (168) | (214) | (189) | (218) | ||||
| Capex | — | — | — | — | — | — | (18) | (35) | (22) | (27) | |||||
| Free cash flow | — | — | — | — | — | — | (187) | (249) | (211) | (245) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | 264 | 118 | 377 | 795 | ||||
| Total debt | — | — | — | — | — | — | 390 | 450 | 435 | 1,240 | |||||
| Net debt | — | — | — | — | — | — | 87 | 252 | (13) | 485 | |||||
| Shareholders’ equity | — | — | — | — | — | — | (1,129) | (1,382) | 56 | 491 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | 0.00 | (44.50) | (100.17) | (15.31) | ||||
| ROIC | — | — | — | — | — | — | 0.00 | 0.00 | (992.66) | (16.20) | |||||
| ROE | — | — | — | — | — | — | 0.00 | 21.18 | 112.58 | (89.48) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Tempus AI, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems Inc. | $50.7B | 50.0× | 26.9× | +17.60% (above 0%: growing) | +36.59% (above 0%: growing) | −0.62% (below 0%: shrinking) | 75.00% | 29.64% | Compare |
| TEM Tempus AI, Inc. | $12.8B | — (loss-making) | — (loss-making) | +21.56% (above 0%: growing) | n/m | −153.72% (below 0%: shrinking) | 64.45% | (19.85%) | |
| BTSG BrightSpring Health Services, Inc. | $12.3B | 34.0× | 37.6× | +23.05% (above 0%: growing) | +192.86% (above 0%: growing) | −39.62% (below 0%: shrinking) | 12.72% | 3.37% | Compare |
| TXG 10x Genomics | $9.4B | — (loss-making) | — (loss-making) | −12.65% (below 0%: shrinking) | n/m | −4.61% (below 0%: shrinking) | 74.48% | (12.95%) | Compare |
| HNGE Hinge Health Inc. | $8.5B | 73.5× | 39.4× | +53.00% (above 0%: growing) | n/m | +441.14% (above 0%: growing) | 86.44% | 19.00% | Compare |
| HQY HealthEquity, Inc. | $7.7B | 33.0× | 30.2× | +7.64% (above 0%: growing) | +14.49% (above 0%: growing) | −3.44% (below 0%: shrinking) | 73.55% | 28.14% | Compare |
| DOCS Doximity, Inc. | $5.6B | 34.8× | 26.2× | +7.34% (above 0%: growing) | −53.57% (below 0%: shrinking) | −34.14% (below 0%: shrinking) | 84.87% | 21.48% | Compare |
| WAY Waystar Holding Corp. | $5.4B | 38.0× | 22.4× | +18.11% (above 0%: growing) | +10.53% (above 0%: growing) | −52.42% (below 0%: shrinking) | 69.44% | 23.79% | Compare |
| HTFL Heartflow, Inc. | $4.4B | — (loss-making) | — (loss-making) | +47.57% (above 0%: growing) | n/m | +62.62% (above 0%: growing) | 83.00% | (27.93%) | Compare |
| Median of peers | $8.1B | 36.4× | 28.5× | +17.86% | +14.49% | −4.02% | 74.74% | 20.24% |
Tempus AI, Inc. (TEM) key facts
- Strength: Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024.
- Tempus AI, Inc. (TEM) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, TEM traded at $64.72, a market capitalization of $12.8 billion.
- Return on equity was −89.5% and debt-to-equity 3.06.
- Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 2.60 (grey zone) for fiscal 2025.